Literature DB >> 30091294

Hospital discharge data under-reports delirium occurrence: results from a point prevalence survey of delirium in a major Australian health service.

Penelope Casey1,2, Wendy Cross3, Melinda Webb-St Mart2, Cathryn Baldwin2, Kath Riddell2, Pēteris Dārziņš1,2.   

Abstract

BACKGROUND: Delirium in hospitalised patients is common, and a risk factor for adverse outcomes. Health services require accurate delirium data to monitor the impact of initiatives designed to improve detection and prevention of delirium. AIM: To determine the extent to which International Classification of Disease codes represent delirium occurrence.
METHODS: A cross-sectional point prevalence survey was used to audit delirium occurrence in 25 inpatient wards of an Australian health service. All adult patients were eligible. Exclusion was for coma, end of life or behaviour that posed a risk to delirium assessors. Specially trained nurses and allied health professionals (AHP) screened patients for any cognitive impairment using the 4 A's Test (4AT). Those with abnormal screen test results were assessed using the '3-Minute Diagnostic Interview for the Confusion Assessment Method' (3D-CAM). Delirium detected by 3D-CAM was the reference standard.
RESULTS: Of potentially eligible patients, 559 of 667 (83.8%) patients were assessed. The mean age was 73 years (±16.4), 54.5% were female and 43.8% (245/559) had cognitive impairment (4AT score ≥1). The occurrence of delirium during hospitalisation as identified by ICD codes was 10.4% (58/559; 95% confidence interval (CI), 7.9-12.7) compared with a point prevalence of 16.2% (91/559; 95% CI, 13.2-19.1). Only 31 of 91 (34.1%) of those with delirium had ICD delirium codes assigned.
CONCLUSION: ICD coding is inadequate to determine in-hospital delirium incidence. Instead, a point prevalence detection of delirium using the methods described above could be used. Health services could apply the described survey method to evaluate their local initiatives for the improvement of delirium detection and prevention.
© 2018 Royal Australasian College of Physicians.

Entities:  

Keywords:  International Classification of Diseases; adult; delirium; mental status and dementia test; prevalence

Mesh:

Year:  2019        PMID: 30091294     DOI: 10.1111/imj.14066

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  6 in total

1.  The DEMS-DOSS study: validating a delirium monitoring tool in hospitalised older adults.

Authors:  Amy Montgomery; Jo-Anne Todd; Cindy Jones; June Koroitamana; Laurie Grealish; Anne Wand; Stephen Billett; Andrew Teodorczuk
Journal:  Age Ageing       Date:  2022-02-02       Impact factor: 12.782

Review 2.  Delirium.

Authors:  Jo Ellen Wilson; Matthew F Mart; Colm Cunningham; Yahya Shehabi; Timothy D Girard; Alasdair M J MacLullich; Arjen J C Slooter; E Wesley Ely
Journal:  Nat Rev Dis Primers       Date:  2020-11-12       Impact factor: 65.038

3.  Validation and Adaptation of the Multidimensional Prognostic Index in an Older Australian Cohort.

Authors:  Kimberley Bryant; Michael J Sorich; Richard J Woodman; Arduino A Mangoni
Journal:  J Clin Med       Date:  2019-11-01       Impact factor: 4.241

4.  Diagnostic Test Accuracy of the 4AT for Delirium Detection: A Systematic Review and Meta-Analysis.

Authors:  Eunhye Jeong; Jinkyung Park; Juneyoung Lee
Journal:  Int J Environ Res Public Health       Date:  2020-10-15       Impact factor: 3.390

5.  Assessing the Accuracy of International Classification of Diseases (ICD) Coding for Delirium.

Authors:  Victoria L Chuen; Adrian C H Chan; Jin Ma; Shabbir M H Alibhai; Vicky Chau
Journal:  J Appl Gerontol       Date:  2022-02-17

6.  Factors associated with the decision to prescribe and administer antipsychotics for older people with delirium: a qualitative descriptive study.

Authors:  Emily J Tomlinson; Helen Rawson; Elizabeth Manias; Nicole Nikki M Phillips; Peteris Darzins; Alison M Hutchinson
Journal:  BMJ Open       Date:  2021-07-07       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.